MetLife (MET) and Primerica (PRI) represent two established players in the insurance and financial services sector, offering investors exposure to life insurance, annuities, and related products. This comparison examines their relative performance, business models, and recent market positioning to assist institutional and retail investors evaluating portfolio allocations or tactical trades. Traders focused on sector rotation and long-term holders assessing dividend stability may find the analysis particularly relevant in the current environment of moderating inflation and anticipated monetary policy adjustments.
MetLife, Inc. operates as a leading global provider of life insurance, employee benefits, and financial services, serving millions of customers across multiple continents. In recent weeks, MET shares have traded near multi-year highs, closing at $96.13 on July 31, 2026, after reaching an intraday peak above $97. The stock delivered a year-to-date return of approximately 23.59%, significantly ahead of the S&P 500 benchmark. Positive sentiment stems from strong first-quarter earnings that exceeded expectations and continued demand for protection products. Upcoming second-quarter results, scheduled for August 5, 2026, represent a key near-term catalyst as investors assess premium growth and investment income trends.
Primerica, Inc. specializes in term life insurance and investment products tailored to middle-income families, operating primarily through a network of independent agents in North America. PRI shares closed at $319.96 on July 31, 2026, after touching a 52-week high near $326.78 earlier in the period. The stock posted a year-to-date gain of roughly 24.95%, modestly ahead of broader market returns. Recent activity reflects resilience supported by solid first-quarter results that included double-digit earnings growth and ongoing share repurchases. Like MET, PRI is set to report second-quarter earnings on August 5, 2026, providing further insight into client acquisition and asset accumulation trends.
Tickeron maintains a curated selection of AI-powered trading bots accessible via its platform. Hundreds of AI Trading Bots trade thousands of different tickers across varied strategies, timeframes, and performance profiles. Only the strongest and most suitable for prevailing market conditions earn placement in the Trending AI Robots section. Available bots exhibit a wide range of historical win rates, average trade durations, and risk metrics, allowing users to explore options aligned with specific objectives. This diversity supports both short-term tactical approaches and longer-horizon systematic strategies. For additional details on current top-performing bots, visit Trending AI Robots.
MetLife’s broad international footprint and diversified product suite provide greater scale and stability compared with Primerica’s more concentrated focus on the U.S. middle-income segment. Growth drivers differ accordingly: MET benefits from group benefits and global expansion, while PRI leverages agent-driven distribution and recurring investment account assets. Recent momentum has favored both, yet PRI recorded slightly higher year-to-date appreciation. Risk factors include interest-rate sensitivity for investment portfolios at MET and agent retention plus economic sensitivity at PRI. Market sentiment appears balanced, with neither stock exhibiting pronounced divergence in analyst coverage or institutional flows during recent market activity.
Based on observable trend consistency, relative year-to-date outperformance, and positioning ahead of shared earnings catalysts, Tickeron’s AI models currently assign a modestly higher probability of favorable near-term behavior to PRI within this pair. This assessment reflects data-driven factors rather than absolute predictions and remains subject to updates with new information.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green whilePRI’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 4 TA indicator(s) are bullish while PRI’s TA Score has 3 bullish TA indicator(s).
MET (@Life/Health Insurance) experienced а +1.37% price change this week, while PRI (@Life/Health Insurance) price change was +1.71% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.10%. For the same industry, the average monthly price growth was +2.15%, and the average quarterly price growth was +5.83%.
MET is expected to report earnings on Aug 05, 2026.
PRI is expected to report earnings on Aug 05, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| MET | PRI | MET / PRI | |
| Capitalization | 61.9B | 9.98B | 620% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 23.587 | 24.948 | 95% |
| P/E Ratio | 18.59 | 13.43 | 138% |
| Revenue | 76B | 3.36B | 2,262% |
| Total Cash | 121B | 1.93B | 6,286% |
| Total Debt | 21.1B | 1.77B | 1,189% |
MET | PRI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 93 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 37 Fair valued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 26 | 10 | |
SMR RATING 1..100 | 96 | 32 | |
PRICE GROWTH RATING 1..100 | 10 | 41 | |
P/E GROWTH RATING 1..100 | 18 | 38 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (37) in the Life Or Health Insurance industry is somewhat better than the same rating for PRI (74). This means that MET’s stock grew somewhat faster than PRI’s over the last 12 months.
PRI's Profit vs Risk Rating (10) in the Life Or Health Insurance industry is in the same range as MET (26). This means that PRI’s stock grew similarly to MET’s over the last 12 months.
PRI's SMR Rating (32) in the Life Or Health Insurance industry is somewhat better than the same rating for MET (96). This means that PRI’s stock grew somewhat faster than MET’s over the last 12 months.
MET's Price Growth Rating (10) in the Life Or Health Insurance industry is in the same range as PRI (41). This means that MET’s stock grew similarly to PRI’s over the last 12 months.
MET's P/E Growth Rating (18) in the Life Or Health Insurance industry is in the same range as PRI (38). This means that MET’s stock grew similarly to PRI’s over the last 12 months.
| MET | PRI | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 62% | 4 days ago 70% |
| Stochastic ODDS (%) | 4 days ago 55% | 4 days ago 54% |
| Momentum ODDS (%) | 4 days ago 67% | N/A |
| MACD ODDS (%) | 4 days ago 64% | 4 days ago 65% |
| TrendWeek ODDS (%) | 4 days ago 59% | 4 days ago 63% |
| TrendMonth ODDS (%) | 4 days ago 53% | 4 days ago 61% |
| Advances ODDS (%) | 7 days ago 64% | 6 days ago 63% |
| Declines ODDS (%) | 12 days ago 52% | 4 days ago 51% |
| BollingerBands ODDS (%) | 4 days ago 60% | 4 days ago 52% |
| Aroon ODDS (%) | 4 days ago 52% | 4 days ago 61% |